WallStSmart
KMTS

Kestra Medical Technologies, Ltd. Common Stock

NASDAQ: KMTS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$19.51
-9.93% today

Updated 2026-04-29

Market cap
$1.14B
P/E ratio
P/S ratio
13.60x
EPS (TTM)
$-5.46
Dividend yield
52W range
$13 – $30
Volume
0.4M

Kestra Medical Technologies, Ltd. Common Stock (KMTS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 5
Last 5 quarters
Avg EPS surprise
-11.0%
Last 4 quarters
Revenue YoY growth
+62.7%
Most recent quarter
EPS YoY growth
+65.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+7.5%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+23.3%
2025-09-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.40+32.6%$21.14$19.56-7.5%
2025-12-11$-0.64-12.3%$24.52$26.17+6.7%
2025-09-12$-0.50+35.6%$18.40$22.68+23.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-01-31$-0.60$-0.40+32.6%$24.55M+62.7%
2025-10-31$-0.57$-0.64-12.3%$22.57M
2025-07-31$-0.78$-0.50+35.6%$19.37M
2025-04-30$-0.53$-1.06-99.9%$17.23M
2025-01-31$-0.64$-1.18-84.4%$15.09M

Frequently asked questions

Has Kestra Medical Technologies, Ltd. Common Stock beaten earnings estimates?
Kestra Medical Technologies, Ltd. Common Stock has beaten Wall Street EPS estimates in 2 of its last 5 quarterly reports, with an average EPS surprise of -11.0% over the last 4 quarters.
How does KMTS stock react to earnings?
KMTS stock has moved an average of +7.5% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Kestra Medical Technologies, Ltd. Common Stock's revenue growth rate?
Kestra Medical Technologies, Ltd. Common Stock reported year-over-year revenue growth of +62.7% in its most recent quarter, with EPS growing +65.7% year-over-year.